Open Questions for Harnessing Autophagy-Modulating Drugs in the SARS-CoV-2 War

doi 10.20944/preprints202004.0022.v1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

SARS-COV-2 and Infectivity

Journal of Medical Virology
VirologyInfectious Diseases
2020English

The Wuhan SARS-CoV-2 - What's Next for China

Journal of Medical Virology
VirologyInfectious Diseases
2020English

FDA Approved Drugs With Broad Anti-Coronaviral Activity Inhibit SARS-CoV-2 in Vitro

2020English

For the People: A Lesson From the SARS-CoV-2 Outbreak

2020English

The SARS-CoV-2 Vaccine Pipeline: An Overview

Current Tropical Medicine Reports
Infectious DiseasesAllergyImmunology
2020English

Monoclonal Antibodies for the S2 Subunit of Spike of SARS-CoV Cross-React With the Newly-Emerged SARS-CoV-2

2020English

While We Wait for a Vaccine Against SARS-CoV-2, Why Not Think About Available Drugs?

2020English

Early Spread of SARS-Cov-2 in the Icelandic Population

2020English

RT‐LAMP for Rapid Diagnosis of Coronavirus SARS‐CoV‐2

Microbial Biotechnology
Applied MicrobiologyBiotechnologyBiochemistryBioengineering
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy